Cargando…
Patient-reported outcomes in urticarial vasculitis treated with omalizumab: case report
BACKGROUND: Despite the current knowledge of UV, there is a lack of consensus among diagnostic criteria and management. In general, antihistamine therapy is regularly used for the symptomatic management of pruritus but does not control inflammation or alter the course of the disease. Monoclonal anti...
Autores principales: | Cherrez-Ojeda, Ivan, Vanegas, Emanuel, Felix, Miguel, Mata, Valeria L., Cherrez, Annia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6203196/ https://www.ncbi.nlm.nih.gov/pubmed/30359231 http://dx.doi.org/10.1186/s12895-018-0077-x |
Ejemplares similares
-
Autoimmune thyroid disease and urticarial vasculitis: is there a significant association?
por: Cherrez-Ojeda, Ivan, et al.
Publicado: (2019) -
Urticarial vasculitis induced by OTC diet pills: a case report
por: Chérrez Ojeda, Iván, et al.
Publicado: (2015) -
Omalizumab for Urticarial Vasculitis: Case Report and Review of the Literature
por: Ghazanfar, Misbah Nasheela, et al.
Publicado: (2015) -
Omalizumab for chronic urticaria in Latin America
por: Wilches, Paul, et al.
Publicado: (2016) -
Pneumomediastinum, Tracheal Diverticulum, and Probable Asthma: Coincidence or Possible Association? A Case Report
por: Cherrez-Ojeda, Ivan, et al.
Publicado: (2018)